Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
The rise in chronic diseases has boosted the demand for assays capable of diagnosing histocompatibility prior to transplantation. Transplantation procedures require diagnostics tests to check HLA and rejection monitoring. Transplantation diagnostics is an administrative as well as clinical tool that detect HLA compatibility between the donor and recipient prior to transplantation procedures and monitors transplanted organs post-surgery for rejection. The market has gained the interest of healthcare providers due to various benefits offered by these tests to assess the feasibility of the organ transplant procedure. According to the estimation of National Kidney Foundation in the US, around 17,107 transplants took place in 2014 and over 3,000 patients are added to the waiting list for kidney each month. There have been significant technological advancements in transplant diagnostics to produce advanced medical specialty choices for the management of organ transplant.
The increase in chronic diseases has elicited the demand for assays capable of diagnosing histocompatibility prior to transplantation. The growth witnessed by transplant diagnostics is mainly driven by the growing public-private funding for target research activities, increasing burden of infectious diseases. The recent growth in funding to research institutes for target research purposes made possible by public-private partnerships is likely to boost market growth over the forecast period. In addition, increasing number of transplant procedures, and technological advancements in the field of transplant diagnostics are factors attributed to the growth of the market. Moreover, adoption of stem cell therapy and personalized medicine is escalating. As a result, demand for pre-procedure diagnostics is growing swiftly. The market growth may have a negative impact attributed to factors such as strict regulatory protocols, slower approval processes and social and ethical controversies in different parts of the world.
The report analyses the transplant diagnostics market based on product and services, technology, transplant type, application, end user and geography.
Different type of transplant diagnostics technology studied in this verticle are molecular assays (PCR Based and Sequencing Based) and non-molecular assay (serological assay and mixed lymphocyte culture) technologies. PCR based molecular assay include Real-Time PCR, Sequence-Specific Primer-PCR, Sequence-Specific Oligonucleotide-PCR etc. Sequencing molecular assay comprises of Sanger Sequencing, Next-Generation Sequencing etc. Molecular assays are preferred by healthcare professionals as compared to non-molecular assays. Currently, PCR-based assay is widely used technique owing to multiple applications. PCR-based assays are powerful tools to predict the blood group of an individual and are rapidly gaining in popularity.
Sequencing-based assay segment is expected to be the fastest growing segment during the forecast period.
The various product and services studied in transplant diagnostics market report include reagents and consumables, instruments, and services and software. Increasing adoption of transplant diagnostic techniques in related research studies and growing number of organ transplantation procedures across major markets are the key factors supporting the growth of the transplant diagnostics market for reagents and consumables. In addition, the key factor accelerating adoption of reagents and consumables is their repeat purchase. Market players are adopting strategies such as purchase contracts for reagents and consumables.
Transplant Diagnostics is carried out for various transplant types solid organ, stem cell, and soft tissue transplantation. The solid organ transplant include Kidney Transplantation Liver Transplantation, Heart Transplantation, Lung Transplantation, Pancreas Transplantation etc. The kidney transplant sub-segment accounted for a key share of the solid organ transplantation segment, in terms of revenue Increasing number of kidney transplantation procedures coupled with the supportive government regulations to augment organ donations across major healthcare markets supporting the segmental growth of the market.
Various applications considered in the study of this market are diagnostic (pre-transplantation diagnostics and post-transplantation diagnostics) and research applications. The pre-transplantation diagnostics application include infectious disease testing, histocompatibility testing and blood profiling. The diagnostic applications segment accounted for the largest share of the market in 2018. The market find major application in diagnostic segment wing to the growing incidence of chronic diseases that may lead to transplantation in critical and terminal patients. Further, growing geriatric population susceptible to the various chronic diseases due to weaker immunity are the key factors supporting the growth of the transplant diagnostics market for diagnostic applications.
End-users of the product comprises hospitals and transplant centers, commercial service providers, research laboratories & academic institutes, and others. The hospitals and transplant centers segment is likely to be the biggest end-user till the end of the assessment period owing to demand for diagnosis of infectious diseases and an increase in surgical procedures.
By geography, the global transplant diagnostic market is studied across the countries of key regions such as, North America, Europe, Asia Pacific and rest of the world regions which includes Latin America, and Middle East & Africa. North America accounted for the largest revenue share in 2018, primarily driven by the rapid increase in geriatric population, high adoption rate of transplantation technique for cancer, and rise in incidence of kidney disorders among geriatric population in the U.S. Further, growing awareness programs about transplantation by pharmaceutical companies is a major practice witnessed in the U.S., which is anticipated to fuel the transplant diagnostic market in this region over the forecast period. The market in Asia Pacific is expected to expand at a rapid pace during the forecast period due to rapidly growing aging population, improving healthcare infrastructure.
Some of the major players operating in this market such as F. Hoffman-La Roche Ltd. (Switzerland), QIAGEN N.V. (Netherlands), Bio-Rad Laboratories, Inc. (US), Thermo Fisher Scientific Inc. (US), and bioMérieux S.A. (France), Immucor, Inc. (US), Illumina, Inc. (US), Luminex Corporation (US), CareDx (US), Becton, Dickinson and Company (US), Hologic (US), and GenDx (Netherlands) among others.
The report analyses the transplant diagnostics market based on product and services, technology, transplant type, application, end user and geography. The various product and services studied in transplant diagnostics market report include reagents and consumables, instruments, and services and software. Different type of transplant diagnostics technology studied in this verticle are molecular assays (PCR Based and Sequencing Based) and non-molecular assay (serological assay and mixed lymphocyte culture) technologies. Transplant Diagnostics is carried out for various transplant types solid organ, stem cell, and soft tissue transplantation. The solid organ transplant include Kidney Transplantation Liver Transplantation, Heart Transplantation, Lung Transplantation, Pancreas Transplantation etc. Various applications considered in the study of this market are diagnostic (pre-transplantation diagnostics and post-transplantation diagnostics) and research applications. The pre-transplantation diagnostics application include infectious disease testing, histocompatibility testing and blood profiling. End-users of the product comprises hospitals and transplant centers, commercial service providers, research laboratories & academic institutes, and others. By geography, the global transplant diagnostic market is studied across the countries of key regions such as, North America, Europe, Asia Pacific and rest of the world regions which includes Latin America, and Middle East & Africa.
Some of the major players operating in this market such as F. Hoffman-La Roche Ltd. (Switzerland), QIAGEN N.V. (Netherlands), Bio-Rad Laboratories, Inc. (US), Thermo Fisher Scientific Inc. (US), and bioMérieux S.A. (France), Immucor, Inc. (US), Illumina, Inc. (US), Luminex Corporation (US), CareDx (US), Becton, Dickinson and Company (US), Hologic (US), and GenDx (Netherlands) among others.
Why to Buy This Report:
